HIV and AIDS Trial, Recruiting NCT07462611 Sponsor: University of Texas Southwestern Medical Center Condition: HIV and AIDS
Back to Hiv Aids

HIV and AIDS Trial, Recruiting

NCT07462611
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For patients visiting the emergency department (ED):

  • People who are able to understand the study and sign a written consent form before the study begins
  • People who test negative for HIV on a rapid test
  • People who meet at least one of the following: they asked their ED doctor about PrEP (a medication to help prevent HIV); they scored above 75% on a tool used to estimate HIV risk; they have previously been diagnosed with a bacterial sexually transmitted infection (STI); they are visiting the ED to get tested for STIs; or their ED doctor referred them as someone who may benefit from PrEP based on general medical guidelines

For ED clinicians (a separate part of the study):

  • Doctors or clinicians who work in the Parkland Emergency Department

Who may not be able to join:

For patients:

  • People who already have a known HIV diagnosis
  • People who test positive for HIV on a rapid test during the visit
  • People who have used PrEP in the last 4 weeks
  • People who have a known allergy or sensitivity to any form of PrEP medication
  • People who are not willing to attend follow-up care at the Parkland Infectious Disease (ID) clinic for ongoing PrEP management
  • People under 18 years of age, adults who are unable to give their own consent, women who are known to be pregnant or breastfeeding at the time of enrolment, or people who are currently in prison

For ED clinicians:

  • People under 18 years of age or people who are currently in prison

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
8 April 2026
Est. completion
31 October 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Evaluate the feasibility of this novel navigation program of rapid-start PrEP in the ED with connection to longitudinal PrEP care and options for long-acting PrEP.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov